Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-01-26
1978-08-22
Schwartz, Gerald A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260613R, 260613D, 568807, 424343, C07C17700, A61K 31055, A61K 31085, A61K 3106
Patent
active
041090152
ABSTRACT:
The disclosure relates to novel 15-(3-aryl- or 3-aralkyl-cyclobutyl, -cyclopentyl and -cyclohexyl)-.omega.-pentanor prostaglandin analogues, for example 9.alpha.,11.alpha.,15.alpha.-trihydroxy-15-(trans-3-phenylcyclobutyl)-16,1 7,18,19,20-pentanor-5-cis, 13-trans-prostadienoic acid, to pharmaceutical or veterinary compositions containing such a compound, and to a method of inducing luteolysis in animals by orally administering such a compound.
REFERENCES:
patent: 3966792 (1976-06-01), Hayashi et al.
Derwent Abstract 64283w/39, (German Pat. No. 2,510,818, 03-14-74 Ono).
Imperial Chemical Industries Limited
Schwartz Gerald A.
LandOfFree
Prostane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostane derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1558780